Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

249
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
249
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

361
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
361
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

317
Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
317
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters00:54

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

452
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
452
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

266
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
266
Oxidation-Reduction Reactions03:11

Oxidation-Reduction Reactions

75.7K
Oxidation–Reduction Reactions
75.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Bayesian-calibrated global sensitivity analysis for mathematical models using generative AI.

PLoS computational biology·2026
查看所有相关文章

相关实验视频

Updated: Feb 1, 2026

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

2.1K

传染病模型的贝叶斯识别分析:参数缩小和模型选择.

Xuyuan Wang1

  • 1Department of mathematical and statistical sciences, University of Alberta, 116 St & 85 Ave, Edmonton, T6G 2R3, Alberta, Canada. xuyuan@ualberta.ca.

Bulletin of mathematical biology
|January 30, 2026
PubMed
概括
此摘要是机器生成的。

在传染病模型中,参数不可识别性是一个主要的挑战. 这项研究将可识别性分析整合到贝叶斯推理中,以改进模型选择和参数估计,以获得更可靠的预测.

关键词:
贝叶斯的推理 贝叶斯的推理数学模型是一个数学模型.模型选择 模型选择无法识别的不可识别性

更多相关视频

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

18.3K
Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori
10:30

Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori

Published on: November 12, 2015

36.5K

相关实验视频

Last Updated: Feb 1, 2026

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

2.1K
A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

18.3K
Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori
10:30

Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori

Published on: November 12, 2015

36.5K

科学领域:

  • 流行病学 流行病学
  • 计算生物学 计算生物学
  • 统计建模 统计建模

背景情况:

  • 传染病模型中的参数不可识别导致不可靠的预测.
  • 解决不可识别问题的现有方法往往是分散的.
  • 将可识别性分析与参数估计的贝叶斯推理集成为未充分探索.

研究的目的:

  • 开发一种在贝叶斯框架内评估参数可识别性的方法.
  • 为了提高马尔科夫链蒙特卡罗 (MCMC) 采样使用识别信息的效率.
  • 通过惩罚无法识别的模型来实现原则性模型选择.

主要方法:

  • 将基于灵敏度矩阵的可识别性分析纳入贝叶斯框架.
  • 设计MCMC算法,利用先前的识别信息来提高采样器性能.
  • 使用抽样结果进行后期不可识别性的评估,以进行实际的可识别性评估.

主要成果:

  • 证明常见的流行病模型 (SIR,SEIR,SEIAR) 通常在有限的数据上几乎无法识别.
  • 验证加强MCMC混合和效率的综合方法.
  • 成功应用原则模型选择方法.

结论:

  • 开发的贝叶斯框架有效地评估和解决传染病模型中的参数不可识别性.
  • 与MCMC采样集成的可识别性分析可以提高计算效率和预测可靠性.
  • 模型节至关重要,而拟议的方法有助于选择更容易识别和更强大的模型.